GLP-1s are basically appetite’s off-switch: suddenly you’re “full” after three bites. Congrats on the smaller meals and ...
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
These will help you build a supportive foundation for the body.
The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the risk of serious kidney injury that can result from dehydration. This comes ...
Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...
MarketBeat on MSN
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector. These treatments are ...
You’ve likely heard of diabetes, a chronic condition that affects how the body regulates blood sugar. But are you familiar ...
More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.
Everyday Health on MSN
How to prevent muscle loss when using Ozempic and other GLP-1s
Learn how to prevent muscle loss while taking GLP-1 medications, with expert tips on protein intake, strength training, and body composition monitoring.
Woman & Home on MSN
'I wanted to test it' - Oprah reveals what happened when she stopped taking weight loss drugs
Oprah Winfrey has spoken openly about using GLP-1s to lose weight in the last few years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results